【持续性肾脏替代治疗CRRT英文精品课件】Cardiorenal syndrome(71p).pptVIP

CRS: Preventive approaches Type III The major management principle concerning this syndrome is Intra- and extravascular volume control with either Use of diuretics and Forms of extracorporeal volume and solute removal CRRT, ultrafiltration, hemodialysis International Journal of Nephrology Volume 2011, Article ID 762590 CRS: Preventive approaches Type III In the setting of AKI, Prevention of left ventricular volume overload is critical to Maintain adequate cardiac output and systemic perfusion and Avoid the viscous downward spiral in both cardiac and renal function International Journal of Nephrology Volume 2011, Article ID 762590 CRS: Preventive approaches Type IV Optimal treatment of CKD with Blood pressure and glycemic control, RAAS blockers, and Disease-specific therapies, when indicated, are the best means of preventing this syndrome International Journal of Nephrology Volume 2011, Article ID 762590 CRS: Preventive approaches Type IV Morbidities of CKD, including Bone and mineral disorder and anemia, should be managed according to CKD guidelines; however, Clinical trials have failed to demonstrate that treatment of these problems influences CVD outcomes International Journal of Nephrology Volume 2011, Article ID 762590 CRS: Preventive approaches Type V There are no proven methods to prevent or ameliorate this form of CRSs at this time Randomized trials of early versus later intervention with CRRT have shown no differential benefit Supportive care with a judicious intravenous fluid approach and the use of pressor agents as needed to avoid hypotension are reasonable but Cannot be expected to avoid AKI or cardiac damage International Journal of Nephrology Volume 2011, Article ID 762590 Conclusions We summarized a newly proposed framework for CRSs in order to better understand five possible subtypes A description of possible heart-kidney interactions is critical to our understanding and will guide future investigations into pathophysiology, scree